Sökning: "therapeutic drug monitoring"
Visar resultat 26 - 30 av 66 avhandlingar innehållade orden therapeutic drug monitoring.
26. Process Analytical Tools for the Monitoring and Characterization of Bacterial Toxins
Sammanfattning : In the era of proteomics, glycomics and ultimately metabolomics, with constantly increasing knowledge regarding the human biosystem, the number of specialized therapeutic agents which will be developed against different diseases is predicted to be on the upswing. An increasing portion of these new drugs will, according to recent predictions (Labrou, 2003), be of proteinaceous origin produced according to biotechnological standards. LÄS MER
27. Drug administration and blood sampling for pharmacokinetic studies in pediatric cancer patients
Sammanfattning : This thesis focuses on drug administration and blood sampling for pharmacokinetic studies in pediatric cancer patients. Only about one third of the drugs used to treat children have been adequately tested with sufficient information regarding safety and efficacy for pediatric patients. LÄS MER
28. Implantable devices in heart failure : studies on biventricular pacing and continuous hemodynamic monitoring
Sammanfattning : Chronic heart failure is a highly symptomatic syndrome associated with increasing prevalence, frequent hospital admissions and high treatment costs. Despite recent advances in drug therapy, morbidity and mortality are still high. LÄS MER
29. Psychotropic drug treatment during pregnancy and lactation : effects on mother and child
Sammanfattning : The common major depressive disorder and anxiety disorders are often treated with antidepressants. Treatment with mood-stabilizers and antipsychotics are important for pregnant women with bipolar and psychotic disorders, as these women are at risk of postpartum psychosis and even suicide if not treated. LÄS MER
30. The usefulness of continuous hemodynamic monitoring to guide therapy in patients with cardiopulmonary disease
Sammanfattning : Introduction: Cardiovascular disease, whether secondary to myocardial injury, pulmonary hypertension or renal failure, have high morbidity and mortality. New treatments have improved quality of life and survival, but hospitalization rates remain high. LÄS MER